Change in alcohol and other drug use during five years of continuous opioid substitution treatment

Abstract

BackgroundEnglish national prospective, observational cohort study of patients continuously enrolled for five years in opioid substitution treatment (OST) with oral methadone and sublingual buprenorphine. This is a secondary outcome analysis of change in use of alcohol and other drug use (AOD) following identification of heroin use trajectories during OST. MethodsAll adults admitted to community OST in 2008/09 and enrolled to 2013/14 (n = 7717). Data from 11 sequential, six-monthly clinical reviews were used to identify heroin and AOD use trajectories by multi-level Latent Class Growth Analysis. OST outcome in the sixth and seventh year was ‘successful completion and no re-presentation’ (SCNR) to structured treatment and was assessed using multi-level logistic regression. ResultsWith 'rapid decreasing' heroin use trajectory as referent, ‘continued high-level’ heroin use predicted ‘continued high-level’ crack cocaine use (relative risk ratio [RRR] 58.7; 95% confidence interval [CI] 34.2–100.5),‘continued high-level’ alcohol use (RRR 1.2; 95% CI 1.0–1.5), ‘increasing’ unspecified drug use (RRR 1.7; 95% CI 1.4–2.1) and less ‘high and increasing’ cannabis use (RRR 0.5; 95% CI 0.4–0.6). 'Increasing’ crack use was negatively associated with SCNR outcome for the ‘decreasing then increasing’ and 'gradual decreasing' heroin use groups (adjusted odds ratio [AOR] 0.5; 95% CI 0.3–0.9 and AOR 0.2; 95% CI 0.1–0.7, respectively). ConclusionsContinued high-level heroin use non-response during long-term OST is associated with high-level crack cocaine and alcohol use, increasing unspecified drug use, but less high and increasing cannabis use. Increasing use of crack cocaine is negatively associated with the likelihood that long-term OST is completed successfully.